Peripheral Neuropathy: Clinical Trials

6 trials for Peripheral Neuropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown. 6 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Unknown 6
Phase 32Unknown 2
Phase 11Unknown 1

Follow Peripheral Neuropathy: new trials by email Literature Review of Peripheral Neuropathy trials Research Report on Peripheral Neuropathy

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vit D and Peripheral Neuropathy in Taxane Naive Patients
Vitamin D - Vitamin D Deficiency, Peripheral Neuropathy
Phase 2UnknownAssiut University602023-07-012023-05-10
Efficacy of Roflumilast in Prevention of Peripheral Neuropathy
Roflumilast, Placebo - Peripheral Neuropathy
Phase 1 / Phase 2UnknownMansoura University602023-07-012023-06-01
Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients
Silymarin, Placebo - Breast Cancer, Peripheral Neuropathy
Phase 2 / Phase 3UnknownTanta University562022-10-282022-10-26
Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy
FOLFOX regimen, HD6610 Granule, HD6610 Granule placebo - Peripheral Neuropathy
Phase 2 / Phase 3UnknownJiangsu Province Hospital of Traditional Chinese Medicine642015-08-012015-12-02
Efficacy and Safety of Lidocaine Infusion Treatment in Management of Neuropathic Pain
Lidocaine HCl, Normal saline - Postherpetic Neuralgia, Diabetic Polyneuropathy
Phase 2UnknownSeoul National University Hospital442015-08-012015-11-05
A Study of Rituxan in the Treatment of Polyneuropathies Associated With Serum IgM Autoantibodies
Rituxan - Peripheral Neuropathy
Phase 2UnknownNational Center for Research Resources (NCRR)2005-06-24

Narrower conditions

Peripheral Nervous System Diseases (6)  ·  Breast Neoplasms (1)  ·  Cardiotoxicity (1)  ·  Cognitive Dysfunction (1)  ·  Colorectal Neoplasms (1)  ·  Diabetic Neuropathies (1)  ·  Neuralgia, Postherpetic (1)  ·  Vitamin D Deficiency (1)

Broader conditions

Nervous System Diseases (6)  ·  Neuromuscular Diseases (6)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Avitaminosis (1)  ·  Breast Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Cognition Disorders (1)  ·  Colonic Diseases (1)  ·  Deficiency Diseases (1)  ·  Diabetes Complications (1)  ·  Diabetes Mellitus (1)  ·  Digestive System Diseases (1)

Interventions

Folfox protocol (1)  ·  Lidocaine (1)  ·  Long-Term Synaptic Depression (1)  ·  Rituximab (1)  ·  Roflumilast (1)  ·  Saline Solution (1)  ·  Silymarin (1)  ·  Vitamin D (1)  ·  XELOX (1)

Sponsors

Assiut University (1)  ·  Jiangsu Province Hospital of Traditional Chinese Medicine (1)  ·  Mansoura University (1)  ·  National Center for Research Resources (NCRR) (1)  ·  Seoul National University Hospital (1)  ·  Tanta University (1)

Countries

China (1)  ·  Egypt (1)  ·  South Korea (1)

Top investigators

Huo JieGe, M.D. (1)  ·  Yong Chul Kim, PhD (1)

Results publications

PMID 29381569

NIH funding

M01RR000036 (1)